Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-022088)

Filing Details

Accession Number:: 0001181431-13-022088
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-12 16:15:26
Reporting Period:: 2013-04-10

Filing Date:: 2013-04-12
Accepted Time:: 2013-04-12 16:15:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1349929	Cancer Genetics Inc	CGIX	Services-Medical Laboratories (8071)	043462475

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1510184	L Andrew Pecora	201 Route 17 North 2Nd Floor Rutherford NJ 07070		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2013-04-10	50,000	$0.00	52,391	No	4	P	Indirect	By limited liability company

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By limited liability company

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Note	Disposition	2013-04-10	0	$0.00	50,000	$10.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The convertible note converted into shares of common stock of Cancer Genetics, Inc. (the "Company") upon consummation of the Company's initial public offering at a conversion price per share equal to the initial public offering price per share. The convertible note had no expiration date.